+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Tumors and malformations in the adult offspring of cyclophosphamide treated and control male rats preliminary communication



Tumors and malformations in the adult offspring of cyclophosphamide treated and control male rats preliminary communication



Mutation Research 229(2): 239-246



Adult offspring aged 52-104 weeks, from male Sprague-Dawley rats treated chronically with cyclophosphamide (CP) were examined for tumours and gross abnormalities. Litter size at birth and at weaning was found to be greatly reduced as a result of paternal CP treatment. No unusual abnormalities were found at post-mortem examination but there was an increase in the incidence of hydronephrosis in offspring from CP-treated males compared with offspring from control males. This increase could have been indirectly caused by CP-treatment through reduced litter size. Histological examination of 26 tumours showed a variety of tumour types in the offspring of CP-treated and control males. Two of the four uterine tumours in offspring from CP-treated males were examined histologically; one was a sarcoma and the other an adenocarcinoma. Although no uterine tumours were found in offspring from control males, it is not clear whether this difference in frequency was treatment-related. The most common tumour site in female offspring from both CP-treated and control males was the mammary gland, and all six of these tumours which were examined histologically were adenofibromas. Abnormal karyotypes were observed in 2 out of 21 offspring showing abnormalities from CP-treated males and none out of 2 offspring with abnormalities from control males. These were not associated with tumours. It was concluded from this limited study that there was no clear evidence of increased tumour incidence in the offspring from CP-treated males. There was an indication that abnormal karyotypes may have been caused by the paternal CP treatment and these abnormalities persisted into adulthood.

(PDF emailed within 1 workday: $29.90)

Accession: 007972182

Download citation: RISBibTeXText

PMID: 2320034


Related references

Increased postimplantation loss and malformations among the F2 progeny of male rats chronically treated with cyclophosphamide. Teratology 45(6): 671-678, 1992

Malformed foetuses and karyotype abnormalities in the offspring of cyclophosphamide and allyl alcohol-treated male rats. Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis 229(2): 173-184, 1990

Male-mediated teratogenesis: spectrum of congenital malformations in the offspring of A/J male mice treated with ethylnitrosourea. Teratogenesis, Carcinogenesis, and Mutagenesis 16(6): 301-305, 1996

Cyclophosphamide in the male rat behavioral effects in the adult offspring. Behavioural Brain Research 16(1): 25-36, 1985

Protective effect of pumpkin seed extract on sperm characteristics, biochemical parameters and epididymal histology in adult male rats treated with cyclophosphamide. Andrologia 46(8): 927-935, 2015

Increased incidence of abnormal fetuses in the offspring of cyclophosphamide treated male mice. Mutation Research 188(1): 57-62, 1987

Congenital malformations in the offspring of male mice treated with ENU at the embryonic stage. Teratology 50(5): 40A, 1994

Protective effect of combined pumpkin seed and ginger extracts on sperm characteristics, biochemical parameters and epididymal histology in adult male rats treated with cyclophosphamide. Anatomical Science International 91(4): 382-390, 2017

Frequency and type of malformations in the offspring of C57BL/6 male mice treated with ethylnitrosourea. Congenital Anomalies. 36(1): 29-33, 1996

Congenital Malformations in the Offspring of Male Mice Treated With Ethylnitrosourea at the Embryonic Stage. Teratogenesis Carcinogenesis & Mutagenesis. 14(6): 271-279, 1994

Congenital malformations in offspring of male mice treated with ethylnitrosourea at the embryonic stage. Teratology 50(6): 17B, 1994

Malformations in newborn rats treated with a single dose of cyclophosphamide. Acta Societatis Medicorum Upsaliensis 76(1-2): 87-90, 1971

Brain myelination in the offspring of ethanol-treated rats: in utero versus lactational exposure by crossfostering offspring of control, pairfed and ethanol treated dams. Brain Research 309(2): 209-216, 1984

Histomorphologic investigations of dentinogenesis in incisors of offspring of cyclophosphamide-treated pregnant rats. Scandinavian Journal of Dental Research 86(6): 444-458, 1978

Paternal cyclophosphamide treatment of rats causes fetal loss and malformations without affecting male fertility. Nature 316(6024): 144-146, 1985